Trials / Completed
CompletedNCT04105998
Effects of Intramuscular (IM) Oxytocin on Pupil Diameter and Heart Rate Variability (HRV)
Effects of Intramuscular Oxytocin on Pupil Diameter and Heart Rate Variability
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 66 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to test the effects of oxytocin on heart rate variability and pupil diameter, both of which have subtle effects on the activity rate of the autonomic nervous system.
Detailed description
This protocol focuses on two measures of autonomic control to quantify central actions of oxytocin. First, the study team proposes to examine the influence of oxytocin on heart rate variability with focus on its effect on high frequency variability, most commonly ascribed to parasympathetic nervous system activity acting to brake sympathetic tone. Intranasal oxytocin has been demonstrated to have a large effect size on this measure which can be repeated at frequent intervals. As a secondary assessment of parasympathetic activity, the study team will measure low frequency fluctuation in pupil diameter, termed hippus, which also reflects parasympathetic nervous system activity. This outcome measure can be assessed in 3 seconds using equipment currently being used under Institutional Review Board (IRB) approved protocols.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin | Oxytocin 10 IU |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2019-10-24
- Primary completion
- 2021-11-01
- Completion
- 2021-11-01
- First posted
- 2019-09-26
- Last updated
- 2022-11-10
- Results posted
- 2022-11-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04105998. Inclusion in this directory is not an endorsement.